Mgp ingredients, inc. (MGPI)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10
Cash Flows from Operating Activities
Net income

38,915

38,793

37,668

38,461

38,077

37,284

38,101

43,230

42,072

41,823

37,469

32,864

32,803

31,184

29,378

26,617

28,180

26,191

27,275

26,732

23,960

23,675

15,751

3,198

-1,621

-4,929

-4,388

2,355

1,225

1,624

17,588

11,661

2,253

1,078

0

0

0

0

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

11,887

11,572

11,370

11,138

11,243

11,362

11,396

11,580

11,499

11,308

11,084

10,824

10,687

11,253

11,732

12,181

12,595

12,382

12,383

12,401

12,374

12,325

12,256

12,166

12,083

12,009

11,843

11,676

11,601

11,568

11,340

10,890

10,347

9,807

0

0

0

0

Gain on sale of bioplastics manufacturing business

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,453

0

0

0

-

-

-

-

-

-

-

-

-

Gain on property insurance recoveries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,055

0

0

0

-

-

-

-

-

Gain on sale of assets

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

832

0

0

0

-

-

-

-

0

Share-based compensation

3,318

3,304

3,387

3,398

3,033

3,099

2,908

2,805

2,737

2,574

2,994

2,905

2,778

2,402

1,535

1,958

1,861

1,414

1,759

1,349

986

930

550

440

728

932

1,311

1,313

969

969

962

929

1,182

1,119

0

0

0

0

Deferred income taxes, including change in valuation allowance

-296

-252

-1,637

-1,847

-1,799

-1,665

3,988

3,572

4,189

3,420

891

645

-549

-681

-3,970

-5,155

-3,998

-1,349

1,050

1,487

457

-1,570

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Equity method investment loss

-

-

-

-

-

-

-

-

-

-348

5,948

5,284

5,024

4,036

9,852

8,953

6,937

6,102

-8,860

-8,918

-8,155

-10,137

-8,045

-6,333

-4,072

204

1,427

1,466

1,680

301

-2,443

257

2,410

2,723

0

0

0

0

Distributions received from equity method investee

-

-

-

-

-

-

-

-

-

-

-

-

-

3,300

3,300

3,300

3,300

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Receivables, net

8,499

2,134

-9,437

5,846

9,353

4,450

12,540

828

-1,855

8,262

277

932

5,183

-4,585

5,515

-2,755

-1,662

-2,002

109

2,016

995

4,851

-253

3,573

-2,481

-7,511

1,502

-4,207

-1,443

7,521

1,291

3,192

4,493

1,861

0

0

0

0

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12

-129

-2,757

-6,151

-7,593

6,241

1,729

4,983

7,115

0

0

0

0

Inventory

31,250

28,162

18,847

11,520

12,454

15,620

17,694

20,936

18,888

14,291

13,990

13,905

11,554

20,106

23,403

26,578

30,729

24,260

20,743

13,070

6,779

-476

-5,336

-9,087

-8,123

-1,542

2,369

4,582

4,753

5,450

5,597

9,525

888

197

0

0

0

0

Prepaid expenses

2,124

728

-239

-968

-924

-862

-623

-30

761

498

1,729

2,040

1,075

622

-1,460

-1,050

-392

-117

804

-255

-47

331

175

233

417

129

-341

755

-16

-261

282

-115

573

-154

0

0

0

0

Income taxes payable (refundable)

-4,474

275

839

3,870

1,429

-1,268

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-78

-1

-59

-22

224

-188

-279

-166

-324

0

0

0

-

-

-

-

-

Accounts payable

7,718

2,107

580

-319

-4,280

-2,542

1,894

5,105

8,245

9,540

4,355

-1,743

115

-3,178

-2,739

-1,445

-1,402

3,653

5,312

563

-1,757

-5,928

-5,108

-147

-4,384

2,571

3,220

-4,085

1,181

-4,302

-4,949

-586

1,614

6,545

0

0

0

0

Accounts payable to affiliate, net

-

-

-

-

-

-

-

-

-

-3,349

-2,484

694

505

1,058

-1,586

-1,834

-1,716

-1,042

646

1,053

1,454

2,129

2,907

3,268

1,843

-2,804

-2,055

-4,611

-4,066

-2,159

-2,048

-1,555

-1,054

2,405

0

0

0

0

Accrued expenses

-404

-4,547

-62

1,033

1,420

551

-1,135

-20

-104

2,278

1,624

473

924

-1,407

-2,228

-2,342

-359

2,351

2,260

2,474

330

-373

1,491

1,247

784

3,264

760

584

218

593

1,050

408

405

-367

0

0

0

0

Income taxes payable/refundable

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Deferred credits

-330

-332

-371

-390

-452

-586

-674

-779

-843

-827

-818

-486

-451

-424

-400

-705

-711

-697

-680

-339

169

174

466

140

-266

-208

-522

-506

-577

-630

-599

-602

-894

-900

0

0

0

0

Other, net

-

-

-

-

-

-588

-373

144

226

289

202

609

587

477

499

162

643

703

989

1,033

612

699

652

727

848

876

935

1,403

1,062

1,081

987

234

883

689

0

0

0

0

Change in derivatives

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,034

150

490

639

0

0

-

0

0

Other, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-481

-428

-432

-78

272

437

434

247

17

0

0

0

-

-

-

-

-2,086

0

0

0

0

Net cash provided by (used in) operating activities

24,053

19,722

44,235

35,308

28,813

33,481

18,683

23,871

35,292

33,471

34,324

30,346

20,420

19,721

7,708

9,777

10,900

18,662

19,855

22,038

22,575

15,812

22,051

18,216

14,104

17,300

6,431

4,403

8,499

-5,026

-3,108

-17,071

-15,902

-5,480

0

0

0

0

Cash Flows from Investing Activities
Cash Flows from Investing Activities
Additions to property, plant, and equipment

18,634

16,730

22,551

24,173

27,809

31,046

26,295

24,187

21,579

21,055

18,886

21,767

21,323

17,922

23,149

28,534

28,549

30,526

22,076

11,439

9,801

6,953

7,557

8,045

7,592

6,208

5,088

6,741

9,543

9,229

8,830

5,747

6,087

10,613

0

0

0

0

Acquisition of business

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investments in/ advances to equity method investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

0

0

0

-

-

-

-

-

Divestiture of equity method investment, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,797

0

0

0

-

-

-

-

-

-

-

-

-

Deferred compensation plan investments

2,367

1,201

-1,189

-1,177

-1,166

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from property insurance recoveries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

Proceeds from sale of property

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,263

3,233

2,311

0

0

0

-

-

-

Other, net

0

-

-

-

0

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-21,213

-17,931

-23,740

-25,350

-28,913

-31,046

-26,309

-1,654

1,191

1,777

2,761

-21,459

-21,084

-17,683

-21,711

-28,304

-28,549

-30,526

-15,008

-2,984

-1,346

1,502

-6,170

-8,045

-7,592

-3,411

-1,675

-2,345

-5,147

3,205

-7,895

-5,734

-6,074

-21,435

0

0

0

0

Cash Flows from Financing Activities
Cash Flows from Financing Activities
Payment of dividends and dividend equivalents

7,202

6,856

6,516

6,177

5,839

5,500

4,813

18,754

18,067

17,380

17,036

2,064

2,754

2,066

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of treasury stock

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of treasury stock for tax withholding on equity-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

1,518

0

0

0

-

-

-

-

672

1,141

1,077

644

540

0

0

0

-

-

-

-

-

-

-

-

-

Exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-646

0

0

0

-

Loan fees paid related to borrowings

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Principal payments on long-term debt

391

386

381

379

374

372

369

366

362

358

355

350

1,997

2,346

2,697

3,015

1,681

1,641

1,596

1,583

1,569

1,555

1,557

1,599

1,641

1,683

1,711

1,697

1,684

1,671

1,659

1,714

1,473

1,236

0

0

0

0

Proceeds from credit agreement - revolver

61,115

17,440

20,340

24,645

32,250

28,966

28,116

30,409

23,171

25,930

24,356

22,587

29,585

27,184

28,375

41,921

33,105

26,092

33,681

28,698

48,456

62,146

62,071

71,159

81,438

95,512

110,881

115,030

112,183

127,089

159,499

236,337

298,232

340,532

0

0

0

0

Payments on credit agreement - revolver

-

-

-

-

-

-

-

-

-

56,885

55,183

20,054

21,475

22,356

11,105

9,152

6,246

3,338

19,934

40,940

59,893

73,476

74,281

76,813

84,749

103,405

112,382

113,747

112,209

122,338

146,001

217,615

282,438

319,476

0

0

0

0

Other, net

2

-76

-78

-78

-78

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan fees incurred with borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

39,819

-3,507

-16,098

-10,076

-1,023

-494

513

-27,848

-35,360

-33,733

-29,972

-2,530

664

-1,216

13,877

15,720

11,258

6,970

-4,721

-15,576

-14,838

-14,530

-15,881

-9,288

-6,512

-11,032

-4,756

-2,058

-3,352

1,438

10,017

15,202

21,263

26,826

0

0

0

0

Increase (decrease) in cash and cash equivalents

42,659

-1,716

4,397

-118

-1,123

1,941

-7,113

-5,631

1,123

1,515

7,113

6,357

0

822

-126

-2,807

-6,391

-4,894

126

3,478

6,391

2,784

0

883

0

2,857

0

0

0

-383

-986

-7,603

-713

-89

0

0

0

0